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Abstract Cysteine peptidase inhibitor genes (ICP) of the cha-
gasin family have been identi¢ed in protozoan (Leishmania mex-
icana and Trypanosoma brucei) and bacterial (Pseudomonas
aeruginosa) pathogens. The encoded proteins have low sequence
identities with each other and no signi¢cant identity with cys-
tatins or other known cysteine peptidase inhibitors. Recombi-
nant forms of each ICP inhibit protozoan and mammalian
clan CA, family C1 cysteine peptidases but do not inhibit the
clan CD cysteine peptidase caspase 3, the serine peptidase tryp-
sin or the aspartic peptidases pepsin and thrombin. The func-
tional homology between ICPs implies a common evolutionary
origin for these bacterial and protozoal proteins.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
A natural cysteine peptidase inhibitor potently e¡ective
against the parasite’s own cysteine peptidases and mammalian
counterparts was discovered in Trypanosoma cruzi and given
the trivial name chagasin [1]. The lack of signi¢cant identity
with proteins of the cystatin class suggested that the inhibitor
is a representative of a previously unknown class of peptidase
inhibitors and this is re£ected in its recent classi¢cation as
clan IX, family I42 in the MEROPS database (http://merops.
sanger.ac.uk). Subsequently, gene fragments predicted to en-
code regions of apparent homology to chagasin were identi-
¢ed in a number of other eukaryotic and prokaryotic genomes
[2]. Comparison of the predicted proteins led to postulations
on the regions that may be involved in binding, but experi-
mental data on the functioning of the proteins were not ob-
tained to test the hypotheses. Initial modelling studies using
the T. cruzi chagasin sequence resulted in the suggestion that
chagasin has an immunoglobulin-type structure and a mode
of interaction with cysteine peptidases similar to that of two
unrelated groups of papain inhibitors, the cystatins and the
thyropins [3]. However, information from additional chaga-
sin-like gene sequences was not consistent with these pro-
posals [2]. We have now characterised representatives of this
class of cysteine peptidase inhibitors (designated ICP, for in-
hibitor of cysteine peptidase), which we have identi¢ed in the
parasitic protozoa Trypanosoma brucei, Leishmania mexicana
and Leishmania major and the bacterium Pseudomonas aeru-
ginosa. In this study we show that these proteins all inhibit
clan CA, family C1 cysteine peptidases and thus that there is
functional homology between the eukaryotic and prokaryotic
ICPs.
2. Materials and methods
2.1. Pathogen materials
T. brucei (EATRO/795), L. mexicana (MNYC/BZ/62/M379) and
L. major (MHOM/JL/80/Friedlin) were cultured and puri¢ed as de-
scribed previously [4^6]. Mid-log phase (multiplicative) and stationary
phase (metacyclic) promastigotes of Leishmania were harvested from
cultures at densities of V5U106 ml31 and V2U107 ml31, respec-
tively. L. mexicana cysteine peptidase null mutants, vcpa, vcpb and
vcpc, were generated previously [7^9]. Genomic DNA of P. aeru-
ginosa (PA01) was obtained from Prof. T.J. Mitchell, University of
Glasgow, UK.
2.2. Cloning
The regions encoding the L. mexicana ICP gene, together with
£anking sequences, were ampli¢ed from genomic DNA using stan-
dard protocols [10] and primers NT103 (TGATGTCGTCGCTG-
TAGCGCAG) and NT104 (TCTGTGAGGGAGGAAGCCAACG)
based on the L. major genomic DNA sequence. Products from two
independent polymerase chain reactions (PCRs) were cloned into
pGEM T EASY and sequenced. Total RNA was prepared from
L. mexicana promastigotes and axenic amastigotes using TRI Reagent
(Sigma). 5P RACE was carried out using NT105 (TGGTTCCTCTG-
CGTTCTTCC) to prime cDNA synthesis, NT107 (ACGTTGAGG-
TGCAACGTGTAC) and the splice leader (SL) primer LMEXSL1
(TAACGCTATATAAGTATCAGTTTC) for the ¢rst PCR and
NT106 (CCAGGATCTCATCGCTGAGC) and the nested SL primer
LMEXSL2 (AGTATCAGTTTCTGTACTTTATTG) for the second
PCR.
2.3. Production of recombinant ICPs and cysteine peptidases
Each ICP gene was ampli¢ed with speci¢c primers from genomic
DNA and inserted into the the NdeI and XhoI sites of pET28(a)þ.
L. mexicana ICP used primers NT109 (TGCTCGAGCTACTTCAC-
GTTGAGGTGCAACG) and NT110 (GCCATATGATCGCCCCG-
CTCAGTGTGAAGG). T. brucei ICP used primers NT90 (GGCTC-
GAGCTATGCGGTGGCCTCGACGTGAATG) and NT91 (GGC-
GCATATGTCCCACAACCTATTTACTGAGG). P. aeruginosa ICP
used primers NT134 (GGCATATGTCCTTTTCCCCCTCCCGTC-
TGCTG) and NT135 (GGACTCGAGTCAGCGCACCTGGATCG-
CGCAGG). Escherichia coli BL21DE3 was transformed with pBP67
(L. mexicana ICP), pBP117 (T. brucei ICP) or pBP109 (P. aeruginosa
ICP). N-terminally (His)6-tagged protein was induced with 1 mM
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IPTG; the Leishmania and Pseudomonas ICPs induced at 37‡C for 4 h,
and the T. brucei ICP at 15‡C overnight. Soluble ICP was puri¢ed on
fast £ow nickel agarose resin using a BIOCAD facility and eluted with
500 mM imidazole. The fractions containing the major protein peak
were dialysed against 100 mM Tris^HCl, 100 mM NaCl, 2 mM
EDTA, 0.05% Triton X-100, pH 8.3 at 4‡C and the sample stored
frozen at 320‡C. Total protein concentration was determined using
the BioRad protein assay.
The N-terminal His-tag was removed using 6 U of thrombin per mg
of ICP over 2 h at 25‡C (Novagen). The streptavidin-labelled throm-
bin was removed following the manufacturer’s instructions and the
released His-tag removed using nickel agarose resin. The sample was
then dialysed as above.
Mammalian cathepsins B and L (Calbiochem), papain and caspase
3 (Sigma), and recombinant cysteine peptidase (CPB2.8vCTE) of
L. mexicana [11] were used. The functional molarities of the Leishma-
nia enzyme, cathepsin L and cathepsin B were determined by active
site titration using N-trans-epoxysuccinyl-L-leucine-4-guanidinobutyla-
mide (E-64) [12]. Papain was used to determine the functional molar-
ity of each ICP preparation [13]. The molar ratio of binding between
CPB2.8vCTE and ICP from L. mexicana was determined by active
site titration [13] at pH 5 using N-benzoyl-PFR-p-nitroanilide hydro-
chloride (Sigma) as substrate.
2.4. ICP:peptidase interactions and Ki determination
The Ki assays were carried out for 1 min in a Perkin Elmer LS 55
luminescent £uorimeter at 37‡C in 0.1 M sodium phosphate bu¡er pH
6.5 with 10 WM Z-FR-7-amino-4-methylcoumarin hydrochloride (FR-
AMC, Sigma), 2 mM EDTA, 1 mM dithiothreitol (DTT), 0.4 nM
functional enzyme and a range of at least 10 di¡erent ICP concen-
trations spanning the estimated Ki value. The Ki was determined from
several independent experiments (nv 2) and derived using the follow-
ing equation: Ki = IC50(1/(1+[S]/Km). The Km of each cysteine pepti-
dase for FR-AMC was determined under the same assay conditions as
used for the Ki determinations but in the absence of inhibitor.
ICPs were tested for inhibitory activity versus other classes of pep-
tidases. The aspartic peptidase pepsin was incubated with ICP at a
molar ratio of 1:40 (L. mexicana) and 1:2 (P. aeruginosa) at 37‡C in
0.5 M NaCl, 0.1 M acetic acid pH 2.5 in the presence or absence of
2 mg ml31 bovine serum albumin (BSA). Proteolysis of bovine serum
albumin and/or ICP was monitored over 2 h by analysis on sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) and
compared with a control sample in which pepsin was omitted to con-
¢rm the stability of ICP at acidic pH. The serine peptidase trypsin was
incubated with each ICP at a molar ratio of 1:30 at 30‡C in 50 mM
Tris^HCl, 10 mM CaCl2 pH 7.2 and proteolysis monitored over 2^4 h
as above. The activity of trypsin was also assayed at 30‡C using 2 mM
N-K-benzoyl-R-p-nitroanilide hydrochloride (Sigma) in the presence
of a 30-fold (P. aeruginosa) and 3400-fold (L. mexicana) molar excess
of ICP. The clan CD cysteine peptidase caspase 3 was assayed at 30‡C
in 20 mM Pipes, 100 mM NaCl, 10 mM DTT, 1 mM EDTA, 0.1%
Chaps, 10% sucrose pH 7.2 using 100 WM Ac-DEVD-AMC (Calbio-
chem) in the presence of a 30-fold molar excess of each ICP.
2.5. Detection and quanti¢cation of ICP in parasite lysates
Parasites pellets were lysed at 109 cells ml31 in 0.25 M sucrose,
0.25% (v/v) Triton X-100, 1 mM phenylmethanesulphonyl £uoride,
1 WM E-64, 10 WM Z-FA-diazomethylketone, 1 WM leupeptin, 1 WM
pepstatin and 5 mM EDTA, pH 5.5 at 4‡C using ¢ve cycles of freeze/
thaw and lysates resolved on 15% SDS^PAGE. Western analysis was
performed as previously described [11]. Polyclonal antiserum raised
against recombinant L. mexicana ICP protein (by Scottish Diagnos-
tics) was a⁄nity puri¢ed on an L. mexicana ICP aminolink column.
Anti-rabbit IgG horseradish peroxidase conjugate (Promega) was de-
tected using Supersignal West Pico chemiluminescent reagent (Pierce).
To quantify the level of ICP in wild-type L. mexicana, Western anal-
ysis was performed on known amounts of stationary phase promas-
tigote lysates and the signal corresponding to ICP compared with
those of a standard curve comprising known amounts of puri¢ed,
recombinant non-His6-tagged L. mexicana ICP resolved on the same
gel. For comparison, the level of CPB was also determined in this way
using antiserum raised against recombinant CPB2.8vCTE [11]. The
mean values V standard deviations were determined from three inde-
pendent experiments.
3. Results
3.1. Analysis of ICP genes
The ICP genes were identi¢ed using Blast searches of the
NCBI databases with the T. cruzi chagasin sequence. We
identi¢ed an open reading frame annotated as a hypothetical
protein of P. aeruginosa (gene PA0778) as ICP. The L. major,
T. brucei and P. aeruginosa ICP gene sequences were con-
¢rmed by analysis of two independent PCR products obtained
from appropriate genomic DNA. The L. mexicana ICP gene
was ampli¢ed using PCR primers directed to the £anks of
the L. major gene. The ICP genes of the pathogens predict
small proteins: L. mexicana, 12.7 kDa; L. major, 13.0 kDa;
T. brucei, 13.5 kDa; P. aeruginosa, 14.6 kDa. Comparison of
the ICP genes revealed 16 identical residues and three motifs
Fig. 1. Alignment of the deduced amino acid sequences of ICP proteins. a: Sequences of L. mexicana ICP (AJ548776), T. cruzi chagasin
(AJ299433), T. brucei ICP (AJ548777) and P. aeruginosa ICP (AAG04167, gene PA0778 [21]) compared with ICP of L. major (AJ548878). The
sequences were aligned using AlignX (Vector NTI). Identical amino acids are shaded black, conservative amino acid changes are shaded grey.
Conserved motifs are underlined. b: Percentage amino acid identities between ICP proteins. The N-terminal extension of P. aeruginosa ICP
and the insertion in T. brucei ICP were removed before comparisons.
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(motif 1, LXS/GNPTTGY/FXW; motif 2, L/MV/LGA/XGG;
and motif 3, LV/XYXRPW/F) that are totally conserved be-
tween the four parasitic protozoa and the bacterium (Fig. 1a).
ICP of T. brucei is unique amongst the trypanosomatid pro-
teins in having a short insertion located between motifs 1 and
2. In addition, ICP from P. aeruginosa possesses an N-termi-
nal extension not present in the other ICP sequences. Apart
from the motifs, the proteins di¡ered quite considerably. With
the exception of the two Leishmania sequences, identities were
in the order of 20^40% (Fig. 1b). There was, however, no
signi¢cant identity or similarity at the primary amino acid
sequence level with any member of the cystatin family or
any other known cysteine peptidase inhibitor.
In order to determine the trans-splice site, PCR was per-
formed on cDNA from L. mexicana promastigotes and amas-
tigotes with a SL primer and an internal primer. An identical
product was detected with each (Fig. 2a) and sequence anal-
ysis con¢rmed the positions of the pyrimidine rich region [14]
required for trans-splicing (Fig. 2b, box 1), the AG dinucleo-
tide splice acceptor (box 2) and the ¢rst ATG codon down-
stream of the splice site (box 3). 5P RACE con¢rmed that
these features are conserved in L. major and L. mexicana.
In L. major, the ¢rst ATG is out of frame with the ICP coding
region and translation from the next available ATG (box 4)
predicts a protein of 13.0 kDa, which is similar in size to the
T. cruzi chagasin. Comparison of recombinant and native ICP
also con¢rmed that the second L. mexicana ATG (box 5) is
the correct initiation codon for this ICP (see below).
3.2. Expression of ICP in Leishmania
The a⁄nity puri¢ed anti-ICP antibody detected a protein of
V13 kDa in lysates of log phase promastigotes, stationary
phase promastigote populations containing metacyclics, and
amastigotes of L. mexicana (Fig. 3A). ICP was detected
with the highest expression in the log phase promastigotes.
The same lysates were probed with antibody raised against
the CPB cysteine peptidase of L. mexicana, which has a
greatly increased level of expression in the amastigote form
of the parasite (Fig. 3B). Approximately equal loading was
con¢rmed by probing with antibody to a constitutively ex-
pressed protein, cdc2-related kinase 3, CRK 3 [15] (Fig.
3C). The relative levels of ICP and CPB were quanti¢ed in
lysates of stationary phase promastigotes and found to be
63V 23 fmol and 252V 38 fmol, respectively.
To test whether ICP expression is modulated by cysteine
peptidase expression, promastigotes and amastigotes from
L. mexicana mutants lacking CPA, CPB and CPC cysteine
peptidase genes [7^9] were analysed. ICP expression did not
appear to be altered in either promastigotes or amastigotes for
any of the cysteine peptidase-de¢cient cell lines when com-
pared with wild-type parasites (data not shown).
3.3. Recombinant ICPs are functionally active against
protozoan and mammalian cysteine peptidases
Expression of the N-terminally (His)6-tagged version of
L. mexicana ICP resulted in about 60 mg l31 of E. coli culture
of a soluble protein of V14 kDa. The (His)6-tag was selec-
tively removed by thrombin treatment resulting in a protein of
V13 kDa. This co-migrated with the native protein as de-
tected by Western analysis, con¢rming the correct identi¢ca-
Fig. 2. 5P RACE analysis of L. mexicana ICP cDNA. cDNA from
L. mexicana promastigotes and amastigotes was analysed by 5P
RACE. a: Agarose gel electrophoresis of PCR products with
LMEXSL2 and NT106 primers: lane 1, promastigotes; lane 2,
amastigotes. The sizes of molecular weight standards are indicated
in kilobase pairs. b: Alignment of L. mexicana and L. major ICP
gene sequences indicating (boxed): 1, pyrimidine-rich sequence; 2,
splice acceptor; 3, ¢rst ATG codon; 4, initiation codon for L. major
ICP; 5, initiation codon for L. mexicana ICP. Identical nucleotides
are shaded.
Fig. 3. Western analysis of the stage-related expression of ICP in
L. mexicana. Lysates (10 Wg protein) of wild-type L. mexicana pro-
mastigotes (P), stationary phase promastigote populations contain-
ing metacyclics (M), and mouse lesion-derived amastigotes (A) re-
solved on 15% SDS^PAGE and probed with anti-L. mexicana ICP
antibody (panel A), anti-CPB2.8 serum (panel B) or anti-CRK
3 serum (panel C). The positions of marker proteins are shown.
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tion of the second ATG as the start codon. Typically, 30^50%
of the recombinant protein was functional as an inhibitor.
Recombinant forms of the ICP of T. brucei were produced
with similar yields and functional molarities.
Both forms (with and without the His-tag) of both ICPs
were potent inhibitors of L. mexicana CPB2.8vCTE (Table 1).
The presence of the (His)6-tag had little or no e¡ect on inter-
action, suggesting that the extreme N-terminal portion of ICP
does not play a signi¢cant role in the interaction with the
target cysteine peptidase. The molar ratio of inhibition ap-
proximated to a 1:1 relationship and inhibition was compet-
itive (results not shown). Interestingly, the ICP of T. brucei
was shown to be more potent against the leishmanial enzyme
than the leishmanial ICP. High a⁄nity interaction was also
observed against mammalian cathepsin L. The ICPs also in-
hibited mammalian cathepsin B, but the Kis were appreciably
higher. ICP of Pseudomonas expressed at low levels in E. coli
(0.5 mg l31 of culture). The puri¢ed His-tagged protein of
V17 kDa inhibited CPB2.8vCTE and also mammalian ca-
thepsin L, albeit the latter Ki being in the nM range.
3.4. ICPs have speci¢city towards clan CA cysteine peptidases
None of the three recombinant ICPs inhibited the clan CD
peptidase mammalian caspase 3 when tested at a molar ratio
of 30:1. All three ICP proteins were also tested for activity
against the serine peptidase trypsin and the aspartic protease
pepsin. When incubated individually at 2^40-fold molar ex-
cesses with the enzymes, the ICPs of L. mexicana and P. aeru-
ginosa were largely degraded within 1^2 h. The ICPs were also
unable to inhibit the proteolysis of BSA by trypsin or pepsin
or of N-K-benzoyl-R-p-nitroanilide hydrochloride by trypsin,
even when the molar excess of L. mexicana ICP was raised to
s 3000:1. Furthermore, thrombin treatment was optimal for
the removal of the His-tag, indicating a lack of inhibition of
this enzyme by the ICPs.
4. Discussion
This study has shown that ICPs from protozoa and bacte-
ria, although sharing low primary amino acid sequence iden-
tity, are all e¡ective inhibitors of clan CA, family C1 cysteine
peptidases from mammals and protozoa. This suggests that
they must have similar tertiary structures, at least in the part
that directly interacts with the target peptidases. The three
highly conserved sequence motifs identi¢ed from the sequence
comparisons could well be central to the formation of the
interacting domains. The trypanosomatid ICPs have greater
potency against CPB2.8vCTE and cathepsin L than against
cathepsin B, as was also found with chagasin of T. cruzi
(Monteiro, A.C.S., Abrahamson, M., Juliano, L., Tempone,
A., Rumjanek, F., Lima, A.P. and Scharfstein, J., unpub-
lished). This is probably due to the presence of the occluding
loop of cathepsin B which obstructs the active site and must
dissociate before inhibitors of the cystatin family can bind and
so inhibit the enzyme [16].
ICPs appear to be speci¢c for clan CA, family C1 cysteine
peptidases and do not inhibit clan CD enzymes. These groups
of enzymes are fundamentally quite distinct and only are sim-
ilar in using cysteine and histidine residues in catalysis [17].
Thus the lack of inhibition of clan CD enzymes by ICP is
consistent with ICP acting by insertion into the active site
cleft rather than binding to the active site cysteine per se.
Clearly such binding will depend upon the complementary
tertiary structures of the enzymes and ICP. Cystatins are
known to bind in this fashion, the N-terminus of the inhibitor
protein being directly involved [18]. The lack of e¡ect upon
inhibitory e⁄cacy of ICPs of the presence of a N-terminal
(His)6-tag, together with the absence of any signi¢cant degree
of conservation of the amino acid residues comprising the
N-terminus of ICPs, suggests that this may not be the case
for ICPs. The total lack of similarity between ICP and cys-
tatins, and indeed thyropins, is consistent with the proteins
interacting di¡erently with the target peptidases.
The role of the ICP proteins in the pathogens is yet to be
elucidated. Possible functions include interaction with the
pathogens’ own cysteine peptidases, or inhibition of host en-
zymes. Several pieces of evidence point to inhibition of host
cysteine peptidases being important. Firstly, under the condi-
tions used, the Leishmania ICP did not have a higher a⁄nity
for its endogenous cysteine peptidases when compared with
other ICPs from di¡erent species. Notably, the T. brucei ICP
exhibited higher a⁄nity. Secondly, the trypanosomatid ICPs
are almost as potent against cathepsin L as against the Leish-
mania enzymes. Thirdly, there is no direct correlation between
the levels of leishmanial ICP and the parasite’s major clan
CA, family C1 cysteine peptidase CPB (Fig. 3). It was sim-
ilarly found that the stage regulation of chagasin was inversely
proportional to that of the major clan CA, family C1 cysteine
peptidases of T. cruzi [1]. Quanti¢cation of ICP and CPB
levels revealed a molar ratio of V1:4 in stationary phase
promastigotes and a predicted molar ratio of at least 1:40
in amastigotes ^ in which ICP levels are lower and CPB levels
are known to be up-regulated greatly [19,20]. Moreover, the
expression levels of leishmanial ICP were una¡ected by dele-
tion of the clan CA, family C1 enzymes CAP, CPB and CPC.
Finally, genomic studies of P. aeruginosa have con¢rmed the
absence of any clan CA, family C1 cysteine peptidases. Never-
theless, the pathogen contains an inhibitory ICP. It has been
suggested [2] that the true target of this bacterial ICP may be
an endogenous serine protease, as the gene for Pseudomonas
ICP is situated next to a gene encoding a Lon-type serine
peptidase. Our ¢nding that ICP does not inhibit the serine
Table 1
Ki values for ICPs versus cysteine peptidases
CPB2.8vCTE (pM) Cathepsin L (pM) Cathepsin B (nM)
Lm (H)6 ICP 268V 49 (n=5) ND 281V 30 (n=2)
Lm (3) ICP 355V 49 (n=5) 496V39 (n=2) ND
Tb (H)6 ICP 75V 9 (n=4) 434V83 (n=4) 75V 20 (n=2)
Tb (3) ICP 71V 7 (n=2) ND ND
Pa (H)6 ICP 495V 29 (n=2) 3607V966 (n=2) ND
The Ki values are expressed as the meanVS.E.M. derived from the number determinations given in parentheses. Lm denotes L. mexicana ; Tb,
T. brucei ; Pa, P. aeruginosa ; (H)6, His-tagged; (3), His-tag removed; ND, not determined.
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peptidases trypsin and thrombin shows that ICPs are not
general serine peptidase inhibitors, although the possibility
that ICPs inhibit other serine peptidases cannot be currently
excluded.
The results of this study show that ICPs with similar inhib-
itory properties occur in a diverse range of pathogens. It re-
mains to be determined whether or not they perform the same
functions within the pathogens and/or in the host^pathogen
interactions, but the data presented suggest that they have a
common evolutionary origin.
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